| Net Cash Provided by (Used in) Operating Activities |
$75,921 |
USD |
-314% |
Q2 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$76,251 |
USD |
-64% |
Q2 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
4,800,000,000 |
shares |
0% |
Q2 2024 |
Q1 2024 |
| Common Stock, Shares, Issued |
95,708,699 |
shares |
598% |
Q2 2024 |
Q1 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$625 |
USD |
-101% |
Q2 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$8,116 |
USD |
-90% |
Q2 2024 |
Q1 2024 |
| Preferred Stock, Shares Issued |
9,918 |
shares |
-0.82% |
Q2 2024 |
Q1 2024 |
| Preferred Stock, Shares Authorized |
20,000,000 |
shares |
0% |
Q2 2024 |
Q1 2024 |
| Additional Paid in Capital |
$2,640,396 |
USD |
25% |
Q2 2024 |
Q1 2024 |
| Preferred Stock, Shares Outstanding |
9,918 |
shares |
-0.82% |
Q3 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2024 |